The health care reform plan that narrowly passed the House Saturday would hit home-health companies such as Amedisys, an analyst told Bloomberg News. Paul Heldman with the Potomac Research Group in Wa…
Already an INSIDER? Sign in.
We are glad you enjoy reading Business Report.
Continue reading this story and get ACCESS to all our content from any device with a subscription now.
- Get access to more than a decade of story archives.
- Get access to our searchable data center of TOP LISTS.
- Get exclusive content only available to INSIDERS.